CastleKeep Investment Advisors
ABBV icon

CastleKeep Investment Advisors’s AbbVie ABBV Stock Holding History

CastleKeep Investment Advisors’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-4,876
Closed -$888K – 94
2024
Q1 		$888K Sell
4,876
-1,792
-27% -$309K 0.64% 63
2023
Q4 		$1.03M Buy
+6,668
New +$972K 0.73% 57

Other funds holding ABBV

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM

CastleKeep Investment Advisors's ABBV Position: Q2 2024 in Review

CastleKeep Investment Advisors sold out of AbbVie (ABBV) in Q2 2024, closing a stake of 4,876 shares — an estimated $888K sold.

CastleKeep Investment Advisors first reported a position in ABBV in Q4 2023 and held it in 2 quarters. The position peaked at $1.03M in Q4 2023. 3,364 funds tracked by Wall St. Rank hold ABBV as of Q2 2024.

  • CastleKeep Investment Advisors reported no remaining AbbVie position as of Q2 2024 after selling out during the quarter.
  • CastleKeep Investment Advisors sold 4,876 AbbVie shares in Q2 2024, an estimated $888K.
  • CastleKeep Investment Advisors first reported a position in AbbVie in Q4 2023 and held it in 2 quarters.
  • CastleKeep Investment Advisors's AbbVie position peaked at $1.03M in Q4 2023.
  • 3,364 funds tracked by Wall St. Rank held AbbVie as of Q2 2024.

Based on CastleKeep Investment Advisors's 13F filing for Q2 2024, filed 14 Feb 2025.